Trinity Biotech (TRIB) Net Income towards Common Stockholders (2016 - 2024)
Historic Net Income towards Common Stockholders for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$16.2 million.
- Trinity Biotech's Net Income towards Common Stockholders fell 19382.72% to -$16.2 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$27.9 million, marking a year-over-year decrease of 2512.22%. This contributed to the annual value of -$31.8 million for FY2024, which is 3240.07% down from last year.
- As of Q4 2024, Trinity Biotech's Net Income towards Common Stockholders stood at -$16.2 million, which was down 19382.72% from -$4.8 million recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's Net Income towards Common Stockholders ranged from a high of $10.7 million in Q3 2020 and a low of -$18.6 million during Q2 2023
- In the last 5 years, Trinity Biotech's Net Income towards Common Stockholders had a median value of -$5.2 million in 2023 and averaged -$4.2 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 43611.89% in 2020, then crashed by 203149.91% in 2022.
- Trinity Biotech's Net Income towards Common Stockholders (Quarter) stood at $9.6 million in 2020, then crashed by 136.75% to -$3.5 million in 2021, then plummeted by 207.43% to -$10.8 million in 2022, then soared by 49.0% to -$5.5 million in 2023, then tumbled by 193.83% to -$16.2 million in 2024.
- Its Net Income towards Common Stockholders was -$16.2 million in Q4 2024, compared to -$4.8 million in Q3 2024 and -$6.9 million in Q2 2024.